Effects of intravenous amlodipine on coronary hemodynamics in subjects with angiographically normal coronary arteries

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 6, 2002, Pages 884-891

  Neglia, Danilo ^a   Gallopin, Michela ^a   Marraccini, Paolo ^a   Simonetti, Ignazio ^a   Micalizzi, Mauro ^a   Macerata, Alberto ^a   Marzilli, Mario ^a   L'Abbate, Antonio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Amlodipine; Calcium channel blockers; Coronary flow; Coronary microcirculation

Indexed keywords

ADENOSINE; AMLODIPINE;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; BOLUS INJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY HEMODYNAMICS; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTRACORONARY INFUSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADENOSINE; ADULT; AGED; AMLODIPINE; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY VESSELS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0036102134     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200206000-00014     Document Type: Article

References (32)

1. Amlodipine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease
2. Amlodipine: A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease
3. For the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
4. Arterial vasodilator effects of the dihydropyridine calcium antagonist amlodipine alone or in combination with verapamil in systemic hypertension
5. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state
6. Effects of amlodipine on renal hemodynamics in mild to moderate hypertensive patients: A randomized controlled study versus placebo
7. Vasodilatory action of amlodipine on rat aorta, pig coronary artery, human coronary artery, and on isolated Langendorff rat heart preparations
8. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent
9. Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs
10. Mechanisms whereby calcium channel antagonists may protect patients with coronary artery disease
11. Longitudinal gradients for endothelium-dependent and -independent vascular responses in the coronary circulation
12. An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease
13. Pharmacodynamics of amlodipine: Hemodynamic effects and antianginal efficacy after atrial pacing
14. Coronary interactions between nifedipine and adenosine in the intact dog heart
15. Effects of nifedipine and diltiazem on coronary reactive hyperaemia
16. The effect of diltiazem on coronary flow reserve in humans
17. Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts
18. Coronary vasoconstriction: Visible and invisible
19. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease
20. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina
21. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
22. Angina due to coronary microvasculature disease in hypertensive patients without left ventricular hypertrophy
23. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
24. Loss of flow-dependent coronary artery dilatation in patients with hypertension
25. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy
26. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure: A quantitative assessment by positron emission tomography
27. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfuntion
28. Prognostic utility of myocardial blood flow assessed by N-13 Ammonia positron emission tomography in patients with idiopathic dilated cardiomyopathy
29. Potential role of the microvasculature in progression of heart failure
30. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT
31. Effects of adenosine on human coronary arterial circulation
32. Coronary effects of adenosine in conscious man